Covid Vaccines in Phase III, New Risk Calculators, and More
Coronavirus News
source
Catch up on the most important updates from this week.
MORE VACCINES ENTER Phase III trials, researchers continue to learn
about the long-term impacts of Covid-19, and risk calculation becomes
increasingly difficult as the country reopens.
When it comes to vaccine development, there are two big issues on the
table, according to WIRED’s Adam Rogers. First you need to develop a
safe vaccine that works. Then “you need a communications strategy that
explains exactly what the drug does and how it does it” so that people
trust the vaccine enough to go get it.
This week, there was plenty of hopeful news related to the first issue.
New research found that a century-old tuberculosis shot could help
protect against Covid-19, though more research is underway and won’t be
completed until early 2021. Meanwhile, two more vaccines, from Novovax
and Johnson & Johnson, entered Phase III trials. Unlike its competitors,
the Johnson & Johnson vaccine doesn’t need to be frozen and requires
only one dose, giving it a leg up. In all likelihood, there will
eventually be several viable vaccines, all of which will be necessary to
make sure everyone is protected worldwide. Though, as Roxanne Khamsi
notes, the fact that most vaccines are being developed in wealthy
countries means they might not work as well for people from poorer
nations.
Read more
source:https://www.youtube.com/watch?v=8c_UJwLq8PI
Why misinformation about COVID-19’s origins keeps going viral
Another piece of coronavirus misinformation is making the rounds.
Here’s how to sift through the muck.
MONIQUE BROUILLETTE AND REBECCA RENNER PUBLISHED SEPTEMBER 18, 2020
source
TWENTY YEARS AGO, data scientist Sinan Aral began to see the formation
of a trend that now defines our social media era: how quickly untrue
information spreads. He watched as false news ignited online discourse
like a small spark that kindles into a massive blaze. Now the director
of the MIT Initiative on the Digital Economy, Aral believes that a
concept he calls the novelty hypothesis demonstrates this almost
unstoppable viral contagion of false news.
“Human attention is drawn to novelty, to things that are new and
unexpected,” says Aral. “We gain in status when we share novel
information because it looks like we're in the know, or that we have
access to inside information.”
Enter the Yan report. On September 14, an article was posted to
Zenodo, an open-access site for sharing research papers, which claimed
that genetic evidence showed that the SARS-CoV-2 coronavirus was made
in a lab, rather than emerging through natural spillover from animals.
The 26-page paper, led by Chinese virologist Li-Meng Yan, a
postdoctoral researcher who left Hong Kong University, has not
undergone peer review and asserts that this evidence of genetic
engineering has been “censored” in the scientific journals. (National
Geographic contacted Yan and the report’s three other authors for
comment but received no reply.)
Read more